Annual Drug Patent Expirations for ISENTRESS
Isentress is a drug marketed by Msd Sub Merck and is included in three NDAs. It is available from nine suppliers. There are six patents protecting this drug and one Paragraph IV challenge.
This drug has thirty patent family members in sixteen countries.
The generic ingredient in ISENTRESS is raltegravir potassium. Nine suppliers are listed for this compound. Additional details are available on the raltegravir potassium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com